Costs for generic hepatitis C drugs available in India would be paid back in 5 to 10 years
Use of the generic versions of directly-acting antiviral (DAA) drugs that are available in India to treat hepatitis C virus (HCV) infection is not only cost effective but actually saves lifetime costs for treating infected ...
May 17, 2017
0
0